Search

Your search keyword '"Masuda, Takaaki"' showing total 379 results
Start Over Author "Masuda, Takaaki"
379 results on '"Masuda, Takaaki"'

2. Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers.

Author

Kobayashi, Yuta, Niida, Atsushi, Nagayama, Satoshi, Saeki, Koichi, Haeno, Hiroshi, Takahashi, Kazuki, Hayashi, Shuto, Ozato, Yuki, Saito, Hideyuki, Hasegawa, Takanori, Nakamura, Hiromi, Tobo, Taro, Kitagawa, Akihiro, Sato, Kuniaki, Shimizu, Dai, Hirata, Hidenari, Hisamatsu, Yuichi, Toshima, Takeo, Yonemura, Yusuke, Masuda, Takaaki, Mizuno, Shinichi, Kawazu, Masahito, Kohsaka, Shinji, Ueno, Toshihide, Mano, Hiroyuki, Ishihara, Soichiro, Uemura, Mamoru, Mori, Masaki, Doki, Yuichiro, Eguchi, Hidetoshi, Oshima, Masanobu, Suzuki, Yutaka, Shibata, Tatsuhiro, and Mimori, Koshi

Subjects
Humans, Microsatellite Instability, Colorectal Neoplasms, Colonic Neoplasms, Mutation, Antigen Presentation, Microsatellite Repeats
Abstract

BACKGROUND: Intratumor heterogeneity (ITH) in microsatellite instability-high (MSI-H) colorectal cancer (CRC) has been poorly studied. We aimed to clarify how the ITH of MSI-H CRCs is generated in cancer evolution and how immune selective pressure affects ITH. METHODS: We reanalyzed public whole-exome sequencing data on 246 MSI-H CRCs. In addition, we performed a multi-region analysis from 6 MSI-H CRCs. To verify the process of subclonal immune escape accumulation, a novel computational model of cancer evolution under immune pressure was developed. RESULTS: Our analysis presented the enrichment of functional genomic alterations in antigen-presentation machinery (APM). Associative analysis of neoantigens indicated the generation of immune escape mechanisms via HLA alterations. Multiregion analysis revealed the clonal acquisition of driver mutations and subclonal accumulation of APM defects in MSI-H CRCs. Examination of variant allele frequencies demonstrated that subclonal mutations tend to be subjected to selective sweep. Computational simulations of tumour progression with the interaction of immune cells successfully verified the subclonal accumulation of immune escape mutations and suggested the efficacy of early initiation of an immune checkpoint inhibitor (ICI) -based treatment. CONCLUSIONS: Our results demonstrate the heterogeneous acquisition of immune escape mechanisms in MSI-H CRCs by Darwinian selection, providing novel insights into ICI-based treatment strategies.

Published
2023

3. Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma.

Author

Kitagawa, Akihiro, Osawa, Tsuyoshi, Noda, Miwa, Kobayashi, Yuta, Aki, Sho, Nakano, Yusuke, Saito, Tomoko, Shimizu, Dai, Komatsu, Hisateru, Sugaya, Maki, Takahashi, Junichi, Kosai, Keisuke, Takao, Seiichiro, Motomura, Yushi, Sato, Kuniaki, Hu, Qingjiang, Fujii, Atsushi, Wakiyama, Hiroaki, Tobo, Taro, Uchida, Hiroki, Sugimachi, Keishi, Shibata, Kohei, Utsunomiya, Tohru, Kobayashi, Shogo, Ishii, Hideshi, Hasegawa, Takanori, Masuda, Takaaki, Matsui, Yusuke, Niida, Atsushi, Soga, Tomoyoshi, Suzuki, Yutaka, Miyano, Satoru, Aburatani, Hiroyuki, Doki, Yuichiro, Eguchi, Hidetoshi, Mori, Masaki, Nakayama, Keiichi, Shimamura, Teppei, Shibata, Tatsuhiro, and Mimori, Koshi

Subjects
Humans, Proteomics, Amino Acids, Branched-Chain, Cholangiocarcinoma, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Transaminases
Abstract

BACKGROUND: Driver alterations may represent novel candidates for driver gene-guided therapy; however, intrahepatic cholangiocarcinoma (ICC) with multiple genomic aberrations makes them intractable. Therefore, the pathogenesis and metabolic changes of ICC need to be understood to develop new treatment strategies. We aimed to unravel the evolution of ICC and identify ICC-specific metabolic characteristics to investigate the metabolic pathway associated with ICC development using multiregional sampling to encompass the intra- and inter-tumoral heterogeneity. METHODS: We performed the genomic, transcriptomic, proteomic and metabolomic analysis of 39-77 ICC tumour samples and eleven normal samples. Further, we analysed their cell proliferation and viability. RESULTS: We demonstrated that intra-tumoral heterogeneity of ICCs with distinct driver genes per case exhibited neutral evolution, regardless of their tumour stage. Upregulation of BCAT1 and BCAT2 indicated the involvement of Val Leu Ile degradation pathway. ICCs exhibit the accumulation of ubiquitous metabolites, such as branched-chain amino acids including valine, leucine, and isoleucine, to negatively affect cancer prognosis. We revealed that this metabolic pathway was almost ubiquitously altered in all cases with genomic diversity and might play important roles in tumour progression and overall survival. CONCLUSIONS: We propose a novel ICC onco-metabolic pathway that could enable the development of new therapeutic interventions.

Published
2023

6. Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence

Author

Hosoda, Kiyotaka, Toshima, Takeo, Takahashi, Junichi, Yonemura, Yusuke, Hisamatsu, Yuichi, Hirose, Kosuke, Masuda, Takaaki, Motomura, Yushi, Abe, Tadashi, Ando, Yuki, Dairaku, Katsushi, Nakano, Yusuke, Hashimoto, Masahiro, Hiraki, Yoshiki, Soejima, Yuji, Yoshizumi, Tomoharu, and Mimori, Koshi

Published
2023
Full Text
View/download PDF

7. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis

Author

Hashimoto, Masahiro, Kojima, Yasuhiro, Sakamoto, Takeharu, Ozato, Yuki, Nakano, Yusuke, Abe, Tadashi, Hosoda, Kiyotaka, Saito, Hideyuki, Higuchi, Satoshi, Hisamatsu, Yuichi, Toshima, Takeo, Yonemura, Yusuke, Masuda, Takaaki, Hata, Tsuyoshi, Nagayama, Satoshi, Kagawa, Koichi, Goto, Yasuhiro, Utou, Mitsuaki, Gamachi, Ayako, Imamura, Kiyomi, Kuze, Yuta, Zenkoh, Junko, Suzuki, Ayako, Takahashi, Kazuki, Niida, Atsushi, Hirose, Haruka, Hayashi, Shuto, Koseki, Jun, Fukuchi, Satoshi, Murakami, Kazunari, Yoshizumi, Tomoharu, Kadomatsu, Kenji, Tobo, Taro, Oda, Yoshinao, Uemura, Mamoru, Eguchi, Hidetoshi, Doki, Yuichiro, Mori, Masaki, Oshima, Masanobu, Shibata, Tatsuhiro, Suzuki, Yutaka, Shimamura, Teppei, and Mimori, Koshi

Published
2024
Full Text
View/download PDF

13. Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer

Author

Ozato, Yuki, Kojima, Yasuhiro, Kobayashi, Yuta, Hisamatsu, Yuuichi, Toshima, Takeo, Yonemura, Yusuke, Masuda, Takaaki, Kagawa, Kouichi, Goto, Yasuhiro, Utou, Mitsuaki, Fukunaga, Mituko, Gamachi, Ayako, Imamura, Kiyomi, Kuze, Yuta, Zenkoh, Junko, Suzuki, Ayako, Niida, Atsushi, Hirose, Haruka, Hayashi, Shuto, Koseki, Jun, Oki, Eiji, Fukuchi, Satoshi, Murakami, Kazunari, Tobo, Taro, Nagayama, Satoshi, Uemura, Mamoru, Sakamoto, Takeharu, Oshima, Masanobu, Doki, Yuichiro, Eguchi, Hidetoshi, Mori, Masaki, Iwasaki, Takeshi, Oda, Yoshinao, Shibata, Tatsuhiro, Suzuki, Yutaka, Shimamura, Teppei, and Mimori, Koshi

Published
2023
Full Text
View/download PDF

14. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin

Author

Shimizu, Dai, Taniue, Kenzui, Matsui, Yusuke, Haeno, Hiroshi, Araki, Hiromitsu, Miura, Fumihito, Fukunaga, Mitsuko, Shiraishi, Kenji, Miyamoto, Yuji, Tsukamoto, Seiichi, Komine, Aya, Kobayashi, Yuta, Kitagawa, Akihiro, Yoshikawa, Yukihiro, Sato, Kuniaki, Saito, Tomoko, Ito, Shuhei, Masuda, Takaaki, Niida, Atsushi, Suzuki, Makoto, Baba, Hideo, Ito, Takashi, Akimitsu, Nobuyoshi, Kodera, Yasuhiro, and Mimori, Koshi

Published
2022
Full Text
View/download PDF

18. Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer

Author

Nakano, Takafumi, primary, Takao, Seiichiro, additional, Dairaku, Katsushi, additional, Uno, Naoki, additional, Low, Siew‐Kee (Amanda), additional, Hashimoto, Masahiro, additional, Tsuda, Yasuo, additional, Hisamatsu, Yuichi, additional, Toshima, Takeo, additional, Yonemura, Yusuke, additional, Masuda, Takaaki, additional, Eto, Ken, additional, Ikegami, Toru, additional, Fukunaga, Yosuke, additional, Niida, Atsushi, additional, Nagayama, Satoshi, additional, and Mimori, Koshi, additional

Published
2024
Full Text
View/download PDF

19. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer

Author

Hashimoto, Masahiro, primary, Masuda, Takaaki, additional, Nakano, Yusuke, additional, Tobo, Taro, additional, Saito, Hideyuki, additional, Koike, Kensuke, additional, Takahashi, Junichi, additional, Abe, Tadashi, additional, Ando, Yuki, additional, Ozato, Yuki, additional, Hosoda, Kiyotaka, additional, Higuchi, Satoshi, additional, Hisamatsu, Yuichi, additional, Toshima, Takeo, additional, Yonemura, Yusuke, additional, Hata, Tsuyoshi, additional, Uemura, Mamoru, additional, Eguchi, Hidetoshi, additional, Doki, Yuichiro, additional, Mori, Masaki, additional, and Mimori, Koshi, additional

Published
2024
Full Text
View/download PDF

25. Depressed Colorectal Cancer: A New Paradigm in Early Colorectal Cancer

Author

Kudo, Shin-ei, Kouyama, Yuta, Ogawa, Yushi, Ichimasa, Katsuro, Hamada, Tsuyoshi, Kato, Kazuki, Kudo, Koki, Masuda, Takaaki, Otsu, Hajime, Misawa, Masashi, Mori, Yuichi, Kudo, Toyoki, Hayashi, Takemasa, Wakamura, Kunihiko, Miyachi, Hideyuki, Sawada, Naruhiko, Sato, Toshiro, Shibata, Tatsuhiro, Hamatani, Shigeharu, Nemoto, Tetsuo, Ishida, Fumio, Niida, Atsushi, Miyano, Satoru, Oshima, Masanobu, Ogino, Shuji, and Mimori, Koshi

Published
2020
Full Text
View/download PDF

29. Abstract 5855: Spatial transcriptomics deciphers the cellular society of advanced colorectal cancer

Author

Hashimoto, Masahiro, primary, Ozato, Yuki, additional, Nakano, Yusuke, additional, Abe, Tadashi, additional, Hisamastu, Yuichi, additional, Toshima, Takeo, additional, Yonemura, Yusuke, additional, Uemura, Mamoru, additional, Masuda, Takaaki, additional, Yamamoto, Hirofumi, additional, Mori, Masaki, additional, Eguchi, Hidetoshi, additional, Doki, Yuichiro, additional, and Mimori, Koshi, additional

Published
2023
Full Text
View/download PDF

30. Abstract 5068: Nintedanib enhances antitumor effects of anti-PD-1 therapies through inhibition of immunosuppressive cells in tumor microenvironment

Author

Suzuki, Ryo, primary, Watanabe, Satoshi, additional, Shono, Kunihiro, additional, Masuda, Takaaki, additional, Sekiya, Tomoki, additional, Goto, Yuka, additional, Fujisaki, Toshiya, additional, Arita, Masashi, additional, Ohtsubo, Aya, additional, Shoji, Satoshi, additional, Tanaka, Tomohiro, additional, Nozaki, Koichiro, additional, Kondo, Rie, additional, Saida, Yu, additional, Hokari, Satoshi, additional, Ohashi, Riuko, additional, Shima, Kenjiro, additional, Kimura, Yosuke, additional, Aoki, Nobumasa, additional, Ohshima, Yasuyoshi, additional, Koya, Toshiyuki, additional, and Kikuchi, Toshiaki, additional

Published
2023
Full Text
View/download PDF

31. Abstract 101: Convergent genomic diversity and novel oncogenic metabolism in intrahepatic cholangiocarcinoma

Author

Nakano, Yusuke, primary, Kitagawa, Akihiro, additional, Hashimoto, Masahiro, additional, Abe, Tadashi, additional, Hisamatsu, Yuichi, additional, Toshima, Takeo, additional, Yonemura, Yusuke, additional, Masuda, Takaaki, additional, Inoue, Akira, additional, Eguchi, Hidetoshi, additional, Doki, Yuichiro, additional, and Mimori, Koshi, additional

Published
2023
Full Text
View/download PDF

32. Abstract 4064: PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer

Author

Watanabe, Satoshi, primary, Takahashi, Miho, additional, Suzuki, Ryo, additional, Arita, Masashi, additional, Sato, Ko, additional, Fujisaki, Toshiya, additional, Ohtsubo, Aya, additional, Shoji, Satoshi, additional, Shono, Kunihiro, additional, Masuda, Takaaki, additional, Sekiya, Tomoki, additional, Nozaki, Koichiro, additional, Tanaka, Tomohiro, additional, Kondo, Rie, additional, Saida, Yu, additional, Hokari, Satoshi, additional, Koya, Toshiyuki, additional, and Kikuchi, Toshiaki, additional

Published
2023
Full Text
View/download PDF

34. Supplementary Figure S4 from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy

Author

Hirata, Hidenari, primary, Niida, Atsushi, primary, Kakiuchi, Nobuyuki, primary, Uchi, Ryutaro, primary, Sugimachi, Keishi, primary, Masuda, Takaaki, primary, Saito, Tomoko, primary, Kageyama, Shun-Ichiro, primary, Motomura, Yushi, primary, Ito, Shuhei, primary, Yoshitake, Tadamasa, primary, Tsurumaru, Daisuke, primary, Nishimuta, Yusuke, primary, Yokoyama, Akira, primary, Hasegawa, Takanori, primary, Chiba, Kenichi, primary, Shiraishi, Yuichi, primary, Du, Junyan, primary, Miura, Fumihito, primary, Morita, Masaru, primary, Toh, Yasushi, primary, Hirakawa, Masakazu, primary, Shioyama, Yoshiyuki, primary, Ito, Takashi, primary, Akimoto, Tetsuo, primary, Miyano, Satoru, primary, Shibata, Tatsuhiro, primary, Mori, Masaki, primary, Suzuki, Yutaka, primary, Ogawa, Seishi, primary, Ishigami, Kousei, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table S1 from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy

Author

Hirata, Hidenari, primary, Niida, Atsushi, primary, Kakiuchi, Nobuyuki, primary, Uchi, Ryutaro, primary, Sugimachi, Keishi, primary, Masuda, Takaaki, primary, Saito, Tomoko, primary, Kageyama, Shun-Ichiro, primary, Motomura, Yushi, primary, Ito, Shuhei, primary, Yoshitake, Tadamasa, primary, Tsurumaru, Daisuke, primary, Nishimuta, Yusuke, primary, Yokoyama, Akira, primary, Hasegawa, Takanori, primary, Chiba, Kenichi, primary, Shiraishi, Yuichi, primary, Du, Junyan, primary, Miura, Fumihito, primary, Morita, Masaru, primary, Toh, Yasushi, primary, Hirakawa, Masakazu, primary, Shioyama, Yoshiyuki, primary, Ito, Takashi, primary, Akimoto, Tetsuo, primary, Miyano, Satoru, primary, Shibata, Tatsuhiro, primary, Mori, Masaki, primary, Suzuki, Yutaka, primary, Ogawa, Seishi, primary, Ishigami, Kousei, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Methods from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy

Author

Hirata, Hidenari, primary, Niida, Atsushi, primary, Kakiuchi, Nobuyuki, primary, Uchi, Ryutaro, primary, Sugimachi, Keishi, primary, Masuda, Takaaki, primary, Saito, Tomoko, primary, Kageyama, Shun-Ichiro, primary, Motomura, Yushi, primary, Ito, Shuhei, primary, Yoshitake, Tadamasa, primary, Tsurumaru, Daisuke, primary, Nishimuta, Yusuke, primary, Yokoyama, Akira, primary, Hasegawa, Takanori, primary, Chiba, Kenichi, primary, Shiraishi, Yuichi, primary, Du, Junyan, primary, Miura, Fumihito, primary, Morita, Masaru, primary, Toh, Yasushi, primary, Hirakawa, Masakazu, primary, Shioyama, Yoshiyuki, primary, Ito, Takashi, primary, Akimoto, Tetsuo, primary, Miyano, Satoru, primary, Shibata, Tatsuhiro, primary, Mori, Masaki, primary, Suzuki, Yutaka, primary, Ogawa, Seishi, primary, Ishigami, Kousei, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

37. Data from The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy

Author

Hirata, Hidenari, primary, Niida, Atsushi, primary, Kakiuchi, Nobuyuki, primary, Uchi, Ryutaro, primary, Sugimachi, Keishi, primary, Masuda, Takaaki, primary, Saito, Tomoko, primary, Kageyama, Shun-Ichiro, primary, Motomura, Yushi, primary, Ito, Shuhei, primary, Yoshitake, Tadamasa, primary, Tsurumaru, Daisuke, primary, Nishimuta, Yusuke, primary, Yokoyama, Akira, primary, Hasegawa, Takanori, primary, Chiba, Kenichi, primary, Shiraishi, Yuichi, primary, Du, Junyan, primary, Miura, Fumihito, primary, Morita, Masaru, primary, Toh, Yasushi, primary, Hirakawa, Masakazu, primary, Shioyama, Yoshiyuki, primary, Ito, Takashi, primary, Akimoto, Tetsuo, primary, Miyano, Satoru, primary, Shibata, Tatsuhiro, primary, Mori, Masaki, primary, Suzuki, Yutaka, primary, Ogawa, Seishi, primary, Ishigami, Kousei, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure S2 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma

Author

Hirata, Hidenari, primary, Sugimachi, Keishi, primary, Komatsu, Hisateru, primary, Ueda, Masami, primary, Masuda, Takaaki, primary, Uchi, Ryutaro, primary, Sakimura, Shotaro, primary, Nambara, Sho, primary, Saito, Tomoko, primary, Shinden, Yoshiaki, primary, Iguchi, Tomohiro, primary, Eguchi, Hidetoshi, primary, Ito, Shuhei, primary, Terashima, Kotaro, primary, Sakamoto, Katsumi, primary, Hirakawa, Masakazu, primary, Honda, Hiroshi, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table S1 from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma

Author

Hirata, Hidenari, primary, Sugimachi, Keishi, primary, Komatsu, Hisateru, primary, Ueda, Masami, primary, Masuda, Takaaki, primary, Uchi, Ryutaro, primary, Sakimura, Shotaro, primary, Nambara, Sho, primary, Saito, Tomoko, primary, Shinden, Yoshiaki, primary, Iguchi, Tomohiro, primary, Eguchi, Hidetoshi, primary, Ito, Shuhei, primary, Terashima, Kotaro, primary, Sakamoto, Katsumi, primary, Hirakawa, Masakazu, primary, Honda, Hiroshi, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Materials and Methods, Legends for Supplementary Figures from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma

Author

Hirata, Hidenari, primary, Sugimachi, Keishi, primary, Komatsu, Hisateru, primary, Ueda, Masami, primary, Masuda, Takaaki, primary, Uchi, Ryutaro, primary, Sakimura, Shotaro, primary, Nambara, Sho, primary, Saito, Tomoko, primary, Shinden, Yoshiaki, primary, Iguchi, Tomohiro, primary, Eguchi, Hidetoshi, primary, Ito, Shuhei, primary, Terashima, Kotaro, primary, Sakamoto, Katsumi, primary, Hirakawa, Masakazu, primary, Honda, Hiroshi, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

41. Data from Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma

Author

Hirata, Hidenari, primary, Sugimachi, Keishi, primary, Komatsu, Hisateru, primary, Ueda, Masami, primary, Masuda, Takaaki, primary, Uchi, Ryutaro, primary, Sakimura, Shotaro, primary, Nambara, Sho, primary, Saito, Tomoko, primary, Shinden, Yoshiaki, primary, Iguchi, Tomohiro, primary, Eguchi, Hidetoshi, primary, Ito, Shuhei, primary, Terashima, Kotaro, primary, Sakamoto, Katsumi, primary, Hirakawa, Masakazu, primary, Honda, Hiroshi, primary, and Mimori, Koshi, primary

Published
2023
Full Text
View/download PDF

42. Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer

Author

MASUDA, TAKAAKI, primary, UEO, HIROAKI, additional, OKUMURA, YUTA, additional, KAI, YUICHIRO, additional, ANDO, YUKI, additional, MASUGUCHI, KEN, additional, KITAGAWA, MIWA, additional, KITAGAWA, AKIHIRO, additional, HAYASHI, NAOKI, additional, TSURUDA, YUSUKE, additional, HISAMATSU, YUICHI, additional, SUEHIRO, SHUJI, additional, OHMURA, HIROFUMI, additional, FUJIYOSHI, KENJI, additional, TANAKA, FUMIAKI, additional, and MIMORI, KOSHI, additional

Published
2023
Full Text
View/download PDF

45. Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer

Author

NAMBARA, SHO, primary, MASUDA, TAKAAKI, additional, HIROSE, KOSUKE, additional, HU, QINGJIANG, additional, TOBO, TARO, additional, OZATO, YUKI, additional, KURASHIGE, JUNJI, additional, HIRAKI, YOSHIKI, additional, HISAMATSU, YUICHI, additional, IGUCHI, TOMOHIRO, additional, SUGIMACHI, KEISHI, additional, OKI, EIJI, additional, YOSHIZUMI, TOMOHARU, additional, and MIMORI, KOSHI, additional

Published
2022
Full Text
View/download PDF

46. Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma

Author

Sugimachi, Keishi, primary, Araki, Hiromitsu, additional, Saito, Hideyuki, additional, Masuda, Takaaki, additional, Miura, Fumihito, additional, Inoue, Kentaro, additional, Shimagaki, Tomonari, additional, Mano, Yohei, additional, Iguchi, Tomohiro, additional, Morita, Masaru, additional, Toh, Yasushi, additional, Yoshizumi, Tomoharu, additional, Ito, Takashi, additional, and Mimori, Koshi, additional

Published
2022
Full Text
View/download PDF

47. Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer

Author

Mochizuki, Kenichi, primary, Kudo, Shin-ei, additional, Kato, Kazuki, additional, Kudo, Koki, additional, Ogawa, Yushi, additional, Kouyama, Yuta, additional, Takashina, Yuki, additional, Ichimasa, Katsuro, additional, Tobo, Taro, additional, Toshima, Takeo, additional, Hisamatsu, Yuichi, additional, Yonemura, Yusuke, additional, Masuda, Takaaki, additional, Miyachi, Hideyuki, additional, Ishida, Fumio, additional, Nemoto, Tetsuo, additional, and Mimori, Koshi, additional

Published
2022
Full Text
View/download PDF

50. Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases

Author

Yoshikawa, Yukihiro, primary, Fukunaga, Mitsuko, additional, Takahashi, Junichi, additional, Shimizu, Dai, additional, Masuda, Takaaki, additional, Mizushima, Tsunekazu, additional, Yamada, Kazutaka, additional, Mori, Masaki, additional, Eguchi, Hidetoshi, additional, Doki, Yuichiro, additional, Ochiya, Takahiro, additional, and Mimori, Koshi, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results